Accumulating evidence suggests that a high tumour burden has a negative effect on
anticancer immunity. The concept of tumour burden, simply defined as the total amount of …

Cancer immunotherapy has revolutionized the treatment landscape in medical oncology, but
its efficacy has been variable across patients. Biomarkers to predict such differential …

Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …

Purpose The efficacy of sublobar resection of primary lung cancer have been proven in
recent years. However, sublobar resection for highly invasive lung cancer increases local …

Background There is a wealth of poorly utilized unstructured data on lymphoma metabolism,
and scientometrics and visualization study could serve as a robust tool to address this issue …

Background Current clinical trials are using radiation therapy (RT) to enhance an antitumor
response elicited by high-dose interleukin (IL)-2 therapy or immune checkpoint blockade …

Hepatocellular carcinoma (HCC) has one of the highest mortality rates among solid cancers.
Late diagnosis and a lack of efficacious treatment options contribute to the dismal prognosis …

Immunotherapy with checkpoint inhibitors has prompted a major change not only in cancer
treatment but also in medical imaging. In parallel with the implementation of new drugs …

Cancer immunotherapy, especially immune-checkpoint inhibitors (ICIs), has paved a new
way for the treatment of many types of malignancies, particularly advanced-stage cancers …

Purpose This study aimed to investigate the value of 18F-fluorodeoxyglucose positron
emission tomography/computed tomography (18F-FDG PET/CT) in predicting early …